Department of Neurology, China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Graduate Institute of Biostatistics, College of Management, China Medical University, Taichung, Taiwan; Department of Healthcare Administration, College of Health Science, Asia University, Taichung, Taiwan.
Eur J Intern Med. 2014 Dec;25(10):956-61. doi: 10.1016/j.ejim.2014.10.017. Epub 2014 Nov 8.
Inflammation-related microvasculr disease, albuminuria, and rapid deterioration of renal function can accelerate the development of end-stage renal disease (ESRD). The role of hip fracture (HFr), a disorder that involves inflammation, in the development of ESRD has not been fully investigated. This study explored whether HFr increases the risk of ESRD.
Taiwan National Health Insurance inpatient claims were used to identify 83,550 patients newly diagnosed with HFr from 2000 to 2006, and 83,550 age- and sex-matched patients without HFr were randomly selected for comparison. Hazards of ESRD combined with HFr, comorbidities, including hypertension, hyperlipidemia, peripheral arterial disease, osteoporosis and asthma, and general health status, with Charlson comorbidity index (CCI), were assessed using data to the end of 2011.
ESRD risk was 1.42-fold higher (95% confidence interval [CI]:1.29-1.33) in the HFr cohort than in the control group, which was computed using the Cox proportional model. Age-specific analysis revealed that the adjusted hazard ratios (aHRs) of ESRD for HFr patients increased slightly as age increased, with an aHR of 1.56 (95% CI:1.35-1.81) for patients 65-74 years old, which gradually decreased to 0.88 (95% CI:0.66-1.18) for patients ≥ 85 years old. ESRD risk increased as HFr severity increased, with an aHR of 6.71 (95% CI:5.90-7.63) for patients with severe HFr.
This study is the first to report that HFr, in combination with underlying osteoporosis-related chronic illness, microvascular disease and chronic inflammation, is associated with an increased risk of ESRD, particularly among relatively younger people.
炎症相关的微血管疾病、蛋白尿和肾功能的快速恶化会加速终末期肾病(ESRD)的发展。涉及炎症的髋部骨折(HFr)在 ESRD 发展中的作用尚未得到充分研究。本研究探讨了 HFr 是否会增加 ESRD 的风险。
利用台湾全民健康保险住院理赔资料,从 2000 年至 2006 年确定了 83550 例新诊断为 HFr 的患者,并随机选择了 83550 名年龄和性别匹配且无 HFr 的患者作为对照组。使用数据至 2011 年底,评估了 ESRD 合并 HFr 的风险、高血压、高血脂、外周动脉疾病、骨质疏松症和哮喘等合并症(采用 Charlson 合并症指数(CCI)评估整体健康状况)。
采用 Cox 比例风险模型计算,HFr 组的 ESRD 风险是对照组的 1.42 倍(95%置信区间[CI]:1.29-1.33)。年龄特异性分析显示,随着年龄的增长,HFr 患者的 ESRD 调整后危险比(aHR)略有增加,65-74 岁患者的 aHR 为 1.56(95% CI:1.35-1.81),逐渐下降至≥85 岁患者的 0.88(95% CI:0.66-1.18)。随着 HFr 严重程度的增加,ESRD 风险也增加,严重 HFr 患者的 aHR 为 6.71(95% CI:5.90-7.63)。
本研究首次报道,HFr 与潜在的骨质疏松症相关慢性疾病、微血管疾病和慢性炎症相结合,与 ESRD 风险增加相关,尤其是在相对较年轻的人群中。